IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: The reduced miR-142 levels and increased PD-1 expression in T cells co-cultured with BC CML MNCs were rescued by anti-IL-6 Ab treatment (Supplementary Figs. 13i, j and 16i, j, right panel).